Trials / Completed
CompletedNCT01162928
Parenteral Nutrition With Intravenous and Oral Fish Oil for Intensive Care Patients
Assessment of the Benefit From Combined Administration of Oral and Intravenous Nutrition - Enriched With Omega-3 Fatty Acids - for Intensive Care Patient
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- B. Braun Melsungen AG · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to assess the effect of fish oil-enriched enteral and parenteral nutrition on blood oxygenation in critically ill patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nutriflex Omega special + Oxepa | 3-chamber-bag combined with enteral nutrition |
| DRUG | Nutriflex Lipid special + Pulmocare | 3-chamber-bag combined with enteral nutrition |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2010-07-15
- Last updated
- 2018-04-27
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01162928. Inclusion in this directory is not an endorsement.